Community/Retail

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how the Pharmacy Disaster Support Center can help pharmacists.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, shares information on the current and future estimates of e-prescribing use.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about what makes patients loyal to one pharmacy.

Treating low back pain with physical therapy soon after symptoms start does not make a clinically important difference when compared with starting therapy later.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some safeguards independent pharmacies can implement to avoid issues with controlled substance prescriptions.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, talks about important health care quality metrics for pharmacists and comments on how pharmacists can be active in driving value-based reimbursement.

As the health care landscape continues to change, pharmacy technicians have been increasingly holding leadership roles on their pharmacy teams.

Elias Cachine, PharmD, BCPS (AQ-10) explains what steps pharmacists should take when treating infections in geriatric patients.

Seven in 10 patients report some extent of nonadherence prior to a hospitalization caused by a cardiovascular event such as acute cardiac failure.

Frances Sochovka was an extraordinary woman. She was dad's favorite aunt, and I was quite fond of her.

The US Senate has launched a bipartisan investigation into prescription drug pricing, targeting Valeant, Turing Pharma, Retrophin, and Rodelis in particular.

When you're out and about in your community, you will probably stumble upon a funny sign or billboard, and pharmacy signs are no exception.

AstraZeneca has entered into a definitive agreement to acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California.

Students can use the Pharmacy Curriculum Outcomes Assessment to show potential employers that they are prepared to enter practice.

The FDA has given breakthrough therapy designation to Daiichi Sankyo and Plexxikon Inc's investigational oral CSF-1R inhibitor pexidartinib to treat tenosynovial giant cell tumor.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Just in time for the pound-packing holidays, a list of the top 10 fattest states has emerged.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.

The FDA has granted priority review for Acadia Pharmaceutical Inc's new drug application (NDA) for pimavanserin (Nuplazid) to treat psychosis associated with Parkinson's disease.

Within weeks of each other, 5 men have died from ingesting what appeared to be counterfeit Xanax.

The value of vitamin D supplementation is regularly debated.

How patients experience heart failure is often worlds apart from the way health care providers understand it.

Critical patient information is not always properly communicated between long-term care (LTC) facilities and geriatric emergency departments (EDs).

Pfizer has announced that it will immediately double the allowable income level for its patient assistance program, enabling more patients in need to receive their Pfizer medicines for free.

Walgreens Healthcare Clinics will soon transition to the Epic electronic health record (EHR) platform in order to further enhance care coordination among providers.

The FDA has approved GlaxoSmithKline's mepolizumab (Nucala) as an add-on maintenance treatment for severe asthma.

Eric Sredzinski, PharmD, talks about improving medication adherence in HIV patients through mobile health technologies developed by the team at Avella Specialty Pharmacy.

A 1961 Oklahoma Board of Pharmacy statute is just now causing tension between pharmacists and physicians.